UPDATED May 10, 2024
Companies which are undervalued more than 20% based on the Discounted Cash Flow valuation.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
GOOGL | US$168.65 | 0.8% | 43.5% | US$2.1t | US$191.48 | PE25.3x | E12.2% | 0.5% | Media | ||
AMZN | US$187.48 | 0.7% | 70.0% | US$2.0t | US$217.51 | PE51.8x | E21.5% | n/a | Retail | ||
2330 | NT$802.00 | 2.8% | 61.7% | NT$20.8t | NT$915.41 | PE24.3x | E16.3% | 1.7% | Semiconductors | ||
NOVO B | kr.883.20 | 3.8% | 50.3% | kr.3.9t | kr.908.65 | PE44.1x | E13.3% | 1.1% | Pharmaceuticals & Biotech | ||
JPM | US$198.77 | 4.3% | 48.2% | US$567.2b | US$207.83 | PB1.9x | E-1.3% | 2.3% | Banks | ||
WMT | US$60.48 | 1.1% | 18.5% | US$487.1b | US$65.42 | PE31.4x | E10.6% | 1.4% | Consumer Retailing | ||
JNJ | US$149.91 | 0.4% | -6.8% | US$360.6b | US$173.26 | PE21.1x | E6.9% | 3.3% | Pharmaceuticals & Biotech | ||
COST | US$787.19 | 5.8% | 56.2% | US$345.5b | US$777.54 | PE51.4x | E7.5% | 0.6% | Consumer Retailing | ||
CVX | US$165.82 | 3.5% | 5.9% | US$304.9b | US$183.37 | PE15.1x | E2.5% | 3.9% | Energy | ||
600519 | CN¥1,738.98 | 2.0% | 1.9% | CN¥2.2t | CN¥2,161.67 | PE28x | E12.7% | 2.9% | Food, Beverage & Tobacco | ||
NESN | CHF95.18 | 3.8% | -17.2% | CHF249.5b | CHF108.33 | PE22.3x | E7.1% | 3.2% | Food, Beverage & Tobacco | ||
KO | US$63.26 | 1.8% | -1.3% | US$270.9b | US$67.09 | PE25.3x | E7.7% | 3.1% | Food, Beverage & Tobacco | ||
CRM | US$276.67 | 1.1% | 37.1% | US$266.9b | US$337.07 | PE64.9x | E18.6% | 0.6% | Software | ||
857 | HK$7.68 | 8.0% | 43.0% | HK$1.9t | HK$7.54 | PE8x | E-6.0% | 6.2% | Energy | ||
PEP | US$179.79 | 2.1% | -8.3% | US$244.8b | US$187.17 | PE26.9x | E9.4% | 3.0% | Food, Beverage & Tobacco | ||
AZN | UK£123.70 | 2.7% | 3.0% | UK£191.8b | UK£133.20 | PE37.9x | E15.9% | 2.0% | Pharmaceuticals & Biotech | ||
SAP | €176.06 | 3.1% | 45.2% | €204.3b | €186.58 | PE79.3x | E33.2% | 1.2% | Software | ||
WFC | US$61.89 | 3.3% | 65.1% | US$213.6b | US$63.35 | PB1.3x | E3.5% | 2.3% | Banks | ||
GE | US$163.38 | -0.4% | 65.4% | US$183.3b | US$180.69 | PE42.7x | E14.2% | 0.7% | Capital Goods | ||
INTU | US$632.31 | 0.5% | 47.9% | US$175.5b | US$692.58 | PE63.9x | E17.5% | 0.6% | Software | ||
CAT | US$354.79 | 5.4% | 69.3% | US$172.0b | US$340.98 | PE15.4x | E-2.2% | 1.5% | Capital Goods | ||
AMGN | US$310.15 | -0.4% | 33.1% | US$167.8b | US$313.81 | PE44.2x | E18.2% | 2.9% | Pharmaceuticals & Biotech | ||
SIE | €188.40 | 6.1% | 25.5% | €147.7b | €190.83 | PE16.7x | E3.8% | 2.5% | Capital Goods | ||
PM | US$99.66 | 2.3% | 4.8% | US$154.6b | US$109.42 | PE19.5x | E10.0% | 5.2% | Food, Beverage & Tobacco |